Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjectsDE HAAS, S. L; SCHOEMAKER, R. C; VAN GERVEN, J. M. A et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 11, pp 1619-1629, issn 0269-8811, 11 p.Article

The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjectsLIEM-MOOLENAAR, M; ZOETHOUT, R. W. M; DE BOER, P et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 11, pp 1671-1679, issn 0269-8811, 9 p.Article

Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal womenRAD, M; HÜMPEL, M; SCHAEFER, O et al.British journal of clinical pharmacology. 2006, Vol 62, Num 3, pp 288-296, issn 0306-5251, 9 p.Article

High concentration of dexamethasone in aqueous and vitreous after subconjunctival injectionWEIJTENS, O; FERON, E. J; SCHOEMAKER, R. C et al.American journal of ophthalmology. 1999, Vol 128, Num 2, pp 192-197, issn 0002-9394Article

The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndromeCATH, D. C; GIJSMAN, H. J; SCHOEMAKER, R. C et al.Psychopharmacologia. 1999, Vol 144, Num 2, pp 137-143, issn 0033-3158Article

Bioavailability and bioequivalence of etonogestrel from two oral formulations of desogestrel : Cerazette® and Liseta®TIMMER, C. J; SRIVASTAVA, N; DIEBEN, T. O. M et al.European journal of drug metabolism and pharmacokinetics. 1999, Vol 24, Num 4, pp 335-343, issn 0378-7966Article

Influence of obesity and body fat distribution on growth hormone kinetics in humansLANGENDONK, J. G; MEINDERS, A. E; BURGGRAAF, J et al.American journal of physiology. Endocrinology and metabolism. 1999, Vol 40, Num 5, pp E824-E829, issn 0193-1849Article

Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjectsVAN GERVEN, J. M. A; RONCARI, G; SCHOEMAKER, R. C et al.British journal of clinical pharmacology. 1997, Vol 44, Num 5, pp 487-493, issn 0306-5251Article

Assessment of changes in liver blood flow after food intake-comparison of ICG clearance and echo-DopplerBURGGRAAF, J; SCHOEMAKER, H. C; COHEN, A. F et al.British journal of clinical pharmacology. 1996, Vol 42, Num 4, pp 499-502, issn 0306-5251Article

Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcoholVAN STEVENINCK, A. L; GIESCHKE, R; SCHOEMAKER, R. C et al.British journal of clinical pharmacology. 1996, Vol 41, Num 6, pp 565-574, issn 0306-5251, 9 p.Article

Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplaseVAN GRIENSVEN, J. M. T; BURGGRAAF, K. J; GERLOFF, J et al.Clinical pharmacology and therapeutics. 1995, Vol 57, Num 4, pp 381-389, issn 0009-9236Article

Plasma amino acids ratios related to brain serotonin synthesis in response to food intake in bulimia nervosaPIJL, H; COHEN, A. F; VERKES, R. J et al.Biological psychiatry (1969). 1995, Vol 38, Num 10, pp 659-668, issn 0006-3223Article

Influence of I-desamino-8-D-vasopressin on endogenous fibrinolysis, haemodynamics and liver blood flow in healthy subjectsBURGGRAAF, J; SCHOEMAKER, H. C; KROON, J. M et al.Clinical science (1979). 1994, Vol 86, Num 5, pp 497-503, issn 0143-5221Article

Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humansPIJL, H; KOPPESCHAAR, P. F; COHEN, A. F et al.International journal of obesity. 1993, Vol 17, Num 9, pp 513-520, issn 0307-0565Article

Pharmacokinetics of saruplase, a recombinant unglycosylated human single-chain urokinase-type plasminogen activator and its effects on fibrinolytic and haemostatic parameters in healthy male subjectsDE BOER, A; KLUFT, C; GERLOFF, J et al.Thrombosis and haemostasis. 1993, Vol 70, Num 2, pp 320-325, issn 0340-6245Article

The pharmacokinetic and pharmacodynamic interactions of ramipril with propranololVAN GRIENSVEN, J. M. T; SEIBERT-GRAFE, M; SCHOEMAKER, H. C et al.European journal of clinical pharmacology. 1993, Vol 45, Num 3, pp 255-260, issn 0031-6970Article

A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocityVAN STEVENINCK, A. L; MANDEMA, J. W; TUK, B et al.British journal of clinical pharmacology. 1993, Vol 36, Num 2, pp 109-115, issn 0306-5251Conference Paper

Characterization of glutathione conjugation in humans : stereoselectivity in plasma elimination pharmacokinetics and urinary excretion of (R)- and (S)-2-bromoisovalerylurea in healthy volunteersMULDERS, T. M. T; VENIZELOS, V; SCHOEMAKER, R et al.Clinical pharmacology and therapeutics. 1993, Vol 53, Num 1, pp 49-58, issn 0009-9236Article

Cardiovascular effects of a novel enkephalin analogue, 443C81, in humansCOHEN, A. F; HARKIN, N; POSNER, J et al.Journal of cardiovascular pharmacology. 1990, Vol 16, Num 3, pp 455-460, issn 0160-2446, 6 p.Article

The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effectsCOHEN, A. F; HAMILTON, M; PHILIPSON, R et al.Clinical pharmacology and therapeutics. 1985, Vol 38, Num 4, pp 381-386, issn 0009-9236Article

Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE162₅ZUURMAN, L; ROY, C; SCHOEMAKER, R. C et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 3, pp 363-371, issn 0269-8811, 9 p.Article

Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteersZUURMAN, L; PASSIER, Pccm; DE KAM, M. L et al.Journal of psychopharmacology (Oxford). 2009, Vol 23, Num 6, pp 633-644, issn 0269-8811, 12 p.Article

Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapyBROEYER, F. J. F; OSANTO, S; RITSEMA VAN ECK, H. J et al.Journal of cancer research and clinical oncology. 2008, Vol 134, Num 9, pp 961-968, issn 0171-5216, 8 p.Article

Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjectsDUMONT, G. J. H; DE VISSER, S. J; COHEN, A. F et al.British journal of clinical pharmacology. 2005, Vol 59, Num 5, pp 495-510, issn 0306-5251, 16 p.Article

The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic systemGIJSMAN, H. J; COHEN, A. F; VAN GERVEN, J. M. A et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 1, pp 7-13, issn 0269-8811, 7 p.Article